A Phase 2 Study of the Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy
Clinical trial NCT07680322 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07680322
- Sponsor
- Aeovian Pharmaceuticals, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.